IKS Health Acquihires ThinkDTM To Expand Patient Access Team
ECONOMY & POLICY

IKS Health Acquihires ThinkDTM To Expand Patient Access Team

IKS Health (IKS) has completed an acquihire of ThinkDTM, an AI-native product, strategy and digital services company, in a move to expand its patient access capabilities. The transaction, announced on 31 March 2026, brings ThinkDTM founder Tij Bedi into the company as Executive Vice President and General Manager, Patient Access and Innovation, and integrates his team of AI technology experts into IKS. The addition is intended to accelerate the firm’s ability to implement AI-driven solutions across patient access functions.

Bedi and his colleagues will lead the strategic expansion, scaling and transformation of patient scheduling, registration, demographic capture, insurance eligibility verification and prior authorisations. The team will focus on building and scaling differentiated patient access solutions, strengthening platform capabilities and driving forward-looking innovation that improves outcomes for healthcare providers and those they serve. The work will include integrating advanced automation and machine learning into workflows to reduce administrative burdens and speed patient throughput.

IKS will pursue strategic partnerships to leverage the novel applications of AI and product design expertise to create differentiated market opportunities. Company leadership emphasised that the new team enhances capabilities in agentic AI and human-in-the-loop approaches, which the firm sees as central to continued growth in revenue optimisation and operational performance. The integration is expected to support scalable deployment of solutions across client networks.

Founded in 2006, IKS operates a Care Enablement platform that integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better clinical and financial outcomes, and sustainable growth across the care journey. The company has received recognition from industry surveys and awards for its performance in AI-driven revenue cycle management and client satisfaction and has been cited by technology partners for augmenting human expertise with AI. IKS serves large health systems, physician groups and speciality practices across the United States.

IKS Health (IKS) has completed an acquihire of ThinkDTM, an AI-native product, strategy and digital services company, in a move to expand its patient access capabilities. The transaction, announced on 31 March 2026, brings ThinkDTM founder Tij Bedi into the company as Executive Vice President and General Manager, Patient Access and Innovation, and integrates his team of AI technology experts into IKS. The addition is intended to accelerate the firm’s ability to implement AI-driven solutions across patient access functions. Bedi and his colleagues will lead the strategic expansion, scaling and transformation of patient scheduling, registration, demographic capture, insurance eligibility verification and prior authorisations. The team will focus on building and scaling differentiated patient access solutions, strengthening platform capabilities and driving forward-looking innovation that improves outcomes for healthcare providers and those they serve. The work will include integrating advanced automation and machine learning into workflows to reduce administrative burdens and speed patient throughput. IKS will pursue strategic partnerships to leverage the novel applications of AI and product design expertise to create differentiated market opportunities. Company leadership emphasised that the new team enhances capabilities in agentic AI and human-in-the-loop approaches, which the firm sees as central to continued growth in revenue optimisation and operational performance. The integration is expected to support scalable deployment of solutions across client networks. Founded in 2006, IKS operates a Care Enablement platform that integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better clinical and financial outcomes, and sustainable growth across the care journey. The company has received recognition from industry surveys and awards for its performance in AI-driven revenue cycle management and client satisfaction and has been cited by technology partners for augmenting human expertise with AI. IKS serves large health systems, physician groups and speciality practices across the United States.

Related Stories

Gold Stories

Next Story
Resources

NCC Founder and Padma Shri Awardee AVS Raju Passes Away at 89

Dr Alluri Venkata Satyanarayana Raju, founder and Chairman Emeritus of NCC Limited and a Padma Shri awardee, passed away in Hyderabad on 13 October 2026. He was 89.Born on 18 April 1937 in Antarvedipalem village in Andhra Pradesh's erstwhile East Godavari district, Raju began his entrepreneurial journey in 1956. He established Nagarjuna Construction Company (NCC) Limited in 1978, which subsequently emerged as one of India's leading construction and infrastructure companies.Under his leadership, NCC became a public limited company in 1990 and expanded into one of India's prominent listed constr..

Next Story
Infrastructure Transport

Embraer to Acquire 51 Per Cent Stake in Mahindra Aerospace Arm

Brazilian aerospace major Embraer will acquire a 51 per cent equity stake in Novavayu Aerospace, a step-down subsidiary of Mahindra and Mahindra, under an Investment Agreement notified by the automobile company in an exchange filing. The transaction will give Embraer control of the aerospace business. Following completion of the acquisition, Novavayu Aerospace will cease to be a wholly owned subsidiary and become an associate of Mahindra Defence Systems, which is a step-down wholly owned subsidiary of Mahindra and Mahindra. The agreement is expected to be completed on or before December 1. Mah..

Next Story
Infrastructure Urban

RBI Opens Special Dollar Window for Three State-Run OMCs

The Reserve Bank of India (RBI) has opened a special facility to meet the entire daily US dollar requirements of three public sector oil marketing companies (OMCs), in a move aimed at easing pressure on the Indian rupee. The facility will take effect on October 12, 2026, and remain available until further notice. Indian Oil Corporation, Hindustan Petroleum Corporation and Bharat Petroleum Corporation are eligible to use the arrangement. Under the facility, the RBI will sell US dollars to the three companies through designated banks, allowing them to meet their oil-import payments without sourc..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code